Syndax Pharmaceuticals Inc (NASDAQ:SNDX) shares, rose in value, with the stock price up by 2.38% to the previous day’s close as strong demand from buyers drove the stock to $21.06.
Actively observing the price movement in the last trading, the stock closed the session at $20.57. Referring to stock’s 52-week performance, its high was $25.34, and the low was $11.22. On the whole, SNDX has fluctuated by -8.71% over the past month.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that SNDX’s technical picture suggests that short-term indicators denote the stock is a Hold on average. However, medium-term indicators have put the stock in the category of 50% Buy while long-term indicators on average have been pointing out that it is a 50% Buy.
The stock’s technical analysis shows that the PEG ratio is about 0, with the price of SNDX currently trading nearly -4.33% and -7.07% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 43.11, while the 7-day volatility ratio is showing 3.12% which for the 30-day chart, stands at 3.68%. Furthermore, Syndax Pharmaceuticals Inc (SNDX)’s beta value is 1.01, and its average true range (ATR) is 0.84.
A comparison of Syndax Pharmaceuticals Inc (SNDX) with its peers suggests the former has fared considerably weaker in the market. SNDX showed an intraday change of 2.38% in last session, and over the past year, it grew by 1.20%%.
Data on historical trading for Syndax Pharmaceuticals Inc (NASDAQ:SNDX) indicates that the trading volumes over the past 3 months, they’ve averaged 1.11 million. According to company’s latest data on outstanding shares, there are 84.83 million shares outstanding.
Nearly 5.17% of Syndax Pharmaceuticals Inc’s shares belong to company insiders and institutional investors own 100.24% of the company’s shares. The stock has fallen by -2.55% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the SNDX stock heading into the next quarter.
